CEACAM5 and neoplasm: Serum miR-126-3p, miR-182-5p, miR-183-5p, and miR-210-3p were also found to possess early detective value for NSCLC patients, exhibiting similar sensitivity and specificity with traditional tumor marker CEA [20].